Save information for later
Sign Up

Learn About Limb-Girdle Muscular Dystrophy Type 2C

What is the definition of Limb-Girdle Muscular Dystrophy Type 2C?
Limb-girdle muscular dystrophy type 2C (LGMD2C) is a genetic condition that affects the voluntary muscles around the hips and shoulders. This condition belongs to a group of muscle disorders called limb-girdle muscular dystrophies, which are characterized by progressive loss of muscle bulk and symmetrical weakening of voluntary muscles. Symptoms may additionally include: enlargement (hypertrophy) of the calf muscle and tongue, diseases of the heart muscle (cardiomyopathy), and respiratory abnormalities. LGMD2C is caused by genetic changes in the SGCG gene and is inherited in an autosomal recessive manner.
What are the alternative names for Limb-Girdle Muscular Dystrophy Type 2C?
  • Limb-girdle muscular dystrophy, type 2C
  • Adhalin deficiency, secondary
  • Autosomal recessive limb-girdle muscular dystrophy type 2C
  • DMDA
  • DMDA1
  • Duchenne-like muscular dystrophy, autosomal recessive, type 1
  • Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5
  • Gamma-sarcoglycan-related LGMD R5
  • Gamma-sarcoglycanopathy
  • LGMD due to gamma-sarcoglycan deficiency
  • LGMD type 2C
  • LGMD2C
  • Limb-girdle muscular dystrophy due to gamma-sarcoglycan deficiency
  • Limb-girdle muscular dystrophy type 2C
  • Limb-girdle muscular dystrophy with gamma-sarcoglycan deficiency
  • Maghrebian myopathy
  • Muscular dystrophy, Duchenne-like
  • Severe childhood autosomal recessive muscular dystrophy, North African type
Who are the top Limb-Girdle Muscular Dystrophy Type 2C Local Doctors?
Distinguished in Limb-Girdle Muscular Dystrophy Type 2C
Neurology | Pediatrics | Pediatric Neurology
Distinguished in Limb-Girdle Muscular Dystrophy Type 2C
Neurology | Pediatrics | Pediatric Neurology

State University Of Iowa

200 Hawkins Dr, 
Iowa City, IA 
Languages Spoken:
English
Accepting New Patients

Katherine Mathews is a Neurologist and a Pediatrics provider in Iowa City, Iowa. Dr. Mathews is rated as a Distinguished provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. Her top areas of expertise are Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, Dystrophinopathy, and Friedreich Ataxia. Dr. Mathews is currently accepting new patients.

David P. Randall
Advanced in Limb-Girdle Muscular Dystrophy Type 2C
Advanced in Limb-Girdle Muscular Dystrophy Type 2C

Advocate Medical Group Neurology

1875 Dempster St, Ste 625/660, 
Park Ridge, IL 
Languages Spoken:
English

David Randall is a Neurologist in Park Ridge, Illinois. Dr. Randall is rated as an Advanced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. His top areas of expertise are Lambert-Eaton Syndrome, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Myasthenia Gravis.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Limb-Girdle Muscular Dystrophy Type 2C
Neurology
Advanced in Limb-Girdle Muscular Dystrophy Type 2C
Neurology

University Of Vermont Medical Center Inc

790 College Pkwy, 
Colchester, VT 
Languages Spoken:
English, Hindi
Offers Telehealth

Rup Tandan is a Neurologist in Colchester, Vermont. Dr. Tandan is rated as an Advanced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myasthenia Gravis, Dysferlinopathy, Primary Lateral Sclerosis, and Thymectomy.

What are the latest Limb-Girdle Muscular Dystrophy Type 2C Clinical Trials?
Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), Type 2C (LGMD2C/R5), and Type 2A (LGMD2A/R1)

Summary: This study will follow participants who are screened and confirmed with a genetic diagnosis of Limb-girdle muscular dystrophy type 2E (LGMD2E/R4), Limb-girdle muscular dystrophy type 2D (LGMD2D/R3), Limb-girdle muscular dystrophy type 2C (LGMD2C/R5), or Limb-girdle muscular dystrophy type 2A (LGMD2A/R1). These enrolled participants will be followed to evaluate mobility and pulmonary function for u...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center